scispace - formally typeset
A

Antongiulio Faggiano

Researcher at Sapienza University of Rome

Publications -  353
Citations -  10467

Antongiulio Faggiano is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 49, co-authored 296 publications receiving 8570 citations. Previous affiliations of Antongiulio Faggiano include Institut Gustave Roussy & University of Ferrara.

Papers
More filters
Journal ArticleDOI

Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

Annamaria Colao, +9 more
- 01 Aug 1999 - 
TL;DR: In conclusion, patients with Cushing's disease still have increased cardiovascular risk and suffer from premature atherosclerosis once cured, and patients was probably due to residual abdominal a long term period of WHR, which was inversely correlated to the duration of CD.
Journal ArticleDOI

Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission.

Antongiulio Faggiano, +7 more
- 01 Jun 2003 - 
TL;DR: The persistence of a metabolic syndrome, vascular damage, and atherosclerotic plaques after cortisol level normalization makes patients with Cushing's disease still at high cardiovascular risk despite disease remission, according to this prospective study.
Journal ArticleDOI

Vitamin D and Cancer

L. Vuolo, +3 more
- 23 Apr 2012 - 
TL;DR: The aim of this review is to highlight the relationship between vitamin D and cancer, summarizing several mechanisms proposed to explain the potential protective effect of vitamin D against the development and progression of cancer.
Journal ArticleDOI

The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery

Rosario Pivonello, +8 more
- 01 Jan 2009 - 
TL;DR: It is demonstrated that cabergoline treatment is effective in controlling cortisol secretion for at least 1-2 yr in more than one third of a limited population of patients with CD.
Journal ArticleDOI

Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy.

Marco Volante, +13 more
- 14 Sep 2007 - 
TL;DR: A scoring system for somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors correlated with in vivo data is proposed, based on the evidence that only membrane (rather that cytoplasmic) staining should be considered for a reliable, standardized and clinically relevant report.